BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3010440)

  • 1. Increased binding to ADP-stimulated platelets and aggregation effect of the dysfibrinogen Oslo I as compared with normal fibrinogen.
    Thorsen LI; Brosstad F; Solum NO; Stormorken H
    Scand J Haematol; 1986 Feb; 36(2):203-10. PubMed ID: 3010440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity labeling of a human platelet membrane protein with 5'-p-fluorosulfonylbenzoyl adenosine. Concomitant inhibition of ADP-induced platelet aggregation and fibrinogen receptor exposure.
    Figures WR; Niewiarowski S; Morinelli TA; Colman RF; Colman RW
    J Biol Chem; 1981 Aug; 256(15):7789-95. PubMed ID: 6267026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ca+2 mobilization and fibrinogen binding of platelets refractory to adenosine diphosphate stimulation.
    Peerschke EI
    J Lab Clin Med; 1985 Aug; 106(2):111-22. PubMed ID: 2991399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation: its relation with ADP-induced fibrinogen binding to platelets and ADP-related membrane enzyme activities.
    Legrand C; Dubernard V; Caen J
    Eur J Biochem; 1984 Aug; 142(3):465-71. PubMed ID: 6088225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competitions between fibrinogen with its degradation products for interactions with the platelet-fibrinogen receptor.
    Thorsen LI; Brosstad F; Gogstad G; Sletten K; Solum NO
    Thromb Res; 1986 Dec; 44(5):611-23. PubMed ID: 3810563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of fibrinogen concentration on the velocity of platelet aggregation.
    Landolfi R; De Cristofaro R; De Candia E; Rocca B; Bizzi B
    Blood; 1991 Jul; 78(2):377-81. PubMed ID: 2070075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP.
    Plow EF; Marguerie GA
    J Biol Chem; 1980 Nov; 255(22):10971-7. PubMed ID: 6253495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADP-induced platelet aggregation depends on the conformation or availability of the terminal gamma chain sequence of fibrinogen. Study of the reactivity of fibrinogen Paris 1.
    Denninger MH; Jandrot-Perrus M; Elion J; Bertrand O; Homandberg GA; Mosesson MW; Guillin MC
    Blood; 1987 Aug; 70(2):558-63. PubMed ID: 3607287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of epinephrine on fibrinogen receptor exposure by aspirin-treated platelets and platelets from concentrates in response to ADP and thrombin.
    Peerschke EI
    Am J Hematol; 1984 May; 16(4):335-45. PubMed ID: 6326566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
    Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure of platelet fibrinogen receptors by ADP and epinephrine.
    Bennett JS; Vilaire G
    J Clin Invest; 1979 Nov; 64(5):1393-401. PubMed ID: 574143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure of fibrinogen receptors on fresh and stored platelets by ADP and epinephrine as single agents and as a pair.
    Di Minno G; Capitanio AM; Thiagarajan P; Martinez J; Murphy S
    Blood; 1983 Jun; 61(6):1054-9. PubMed ID: 6301579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral contraceptives, or lanosterol, on ADP-induced aggregation and binding of 125I-fibrinogen to rat platelets.
    McGregor L; Toor B; McGregor JL; Renaud S; Clemetson KJ
    Thromb Res; 1984 Mar; 33(5):517-22. PubMed ID: 6719398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of human blood platelets with three circulating plasma fibrinogens of different molecular weights.
    Thorsen LI; Holm B; Brosstad F; Solum NO
    Thromb Res; 1987 Sep; 47(6):683-92. PubMed ID: 3686483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry.
    Shattil SJ; Cunningham M; Hoxie JA
    Blood; 1987 Jul; 70(1):307-15. PubMed ID: 3297204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the interactions of fibrinogen and soluble fibrin with washed rabbit platelets stimulated with ADP.
    Harfenist EJ; Packham MA; Mustard JF
    Thromb Haemost; 1985 Apr; 53(2):183-7. PubMed ID: 3927504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on platelets of patients with inherited platelet disorders suggest that collagen-induced fibrinogen binding to membrane receptors requires secreted ADP but not released alpha-granule proteins.
    Legrand C; Nurden AT
    Thromb Haemost; 1985 Oct; 54(3):603-6. PubMed ID: 3003952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of fibrinogen to ADP-treated platelets. Comparison of plasma fibrinogen fractions and early plasmic fibrinogen derivatives.
    Peerschke EI; Galanakis DK
    J Lab Clin Med; 1983 Mar; 101(3):453-60. PubMed ID: 6827176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.